Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,089 JPY | -0.02% | +0.49% | +0.86% |
Apr. 26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
Apr. 26 | Hutchmed notes CHMP's positive opinion for fruiquintinib approval | AN |
Evolution of the average Target Price on Takeda Pharmaceutical Company Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Takeda Pharmaceutical Company Limited
Jefferies & Co. | |
TD Cowen | |
BofA Securities | |
Cowen | |
Morgan Stanley |
EPS Revisions
- Stock Market
- Equities
- 4502 Stock
- Consensus Takeda Pharmaceutical Company Limited